Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Thyroid Eye Disease (TED) Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The thyroid eye disease (ted) market size has experienced significant growth in recent years. It is projected to increase from $2.15 billion in 2024 to $2.29 billion in 2025, at a compound annual growth rate (CAGR) of 6.7%. This past expansion can be ascribed to a rise in thyroid disorders, an increasing focus on patient-centered care, a growing demand for cosmetic procedures, the rising prevalence of the disease, and the expanding array of treatment options available for TED.
The market for thyroid eye disease (ted) is projected to experience robust expansion over the coming years, anticipated to reach $2.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth is driven by factors such as the rising incidence of Graves’ disease, increased financial investment across different sectors, higher healthcare spending, broader adoption of thyroid hormone replacement therapy, and a general increase in thyroid disease cases. Key developments expected during this timeframe encompass technological breakthroughs, intensified research and development efforts, the creation of innovative medications, improvements in therapeutic choices, and the introduction of advanced surgical methods.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp
What Are The Drivers Pushing New Developments In The Thyroid Eye Disease (TED) Market?
The thyroid eye disease (TED) market is anticipated to expand in the future due to an increase in thyroid disorders. These disorders are health issues impacting the thyroid gland’s function, causing hormonal imbalances and manifesting as conditions like hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. The surge in thyroid disorders is fueled by elements such as elevated iodine consumption, autoimmune diseases, genetic susceptibility, and enhanced awareness, which contributes to better diagnostic rates. Thyroid Eye Disease (TED) itself adds to the growing number of thyroid disorder cases, being a frequent and severe complication of Graves’ disease, thereby heightening the overall impact and recognition of conditions linked to the thyroid. As an example, in May 2024, the Canadian Cancer Society, a non-profit organization based in Canada, reported that approximately 6,600 new thyroid cancer cases are predicted for diagnosis in Canada in 2024, alongside an estimated 280 fatalities. Consequently, the increase in thyroid disorders is propelling the expansion of the thyroid eye disease (TED) market.
What Are The Major Segment Types Covered In The Thyroid Eye Disease (TED) Market?
The thyroid eye disease (ted)market covered in this report is segmented –
1) By Treatment Type: Medical; Surgical; Combination Of Medical And Surgical
2) By Disease Severity: Mild; Moderate; Severe
3) By Drug Type: Biologics; Small Molecules; Others Drug Type
4) By Route Of Administration: Oral; Intravenous; Subcutaneous
5) By End User: Hospitals; Clinics; Other End Users
Subsegments:
1) By Medical: Corticosteroids; Teprotumumab; Antithyroid Medications; Other Medical Treatments
2) By Surgical: Orbital Decompression Surgery; Eyelid Surgery; Strabismus Surgery
3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression; Combination of Teprotumumab and Eyelid Surgery; Other Combined Approaches
What Key Innovation Trends Are Fueling Advancements In The Thyroid Eye Disease (TED) Market?
Leading firms within the thyroid eye disease (TED) market are prioritizing cutting-edge solutions, notably monoclonal antibody therapies, to create more potent, precisely aimed treatments capable of decreasing inflammation, alleviating proptosis, and ultimately bettering patient results. These therapies involve the application of antibodies produced in laboratories, engineered to replicate the immune system’s natural capacity to pinpoint and eliminate particular disease-causing agents or atypical cells. Illustrating this, Amgen Inc., a US biotechnology firm, disclosed in September 2024 that Japan’s Ministry of Health, Labour and Welfare (MHLW) granted approval for TEPEZZA (teprotumumab) to address active thyroid eye disease (TED), which is a rare autoimmune condition that could imperil vision. This treatment stands as the singular FDA-approved option specifically for TED, providing a focused approach to mitigate inflammation, swelling, and other severe symptoms linked to the illness. The endorsement holds significant importance for Japanese patients, presenting a novel and efficacious way to manage TED, a rare and worsening ailment characterized by severe eye bulging, visual impairment, and ocular discomfort.
Which Key Players Are Driving Competition In The Thyroid Eye Disease (TED) Market?
Major companies operating in the thyroid eye disease (TED) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report
Which Region Is Projected To Lead The Thyroid Eye Disease (TED) Market During The Forecast Period?
North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Thyroid Eye Disease (TED) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21300&type=smp
Browse Through More Reports Similar to the Global Thyroid Eye Disease (TED) Market 2025, By The Business Research Company
Thyroid Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report
Anti Thyroid Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report
Parathyroid Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model